Bharat Biotech’s intra-nasal COVID vaccine gets DCGI nod for phase-II and -III trials Press Trust of India Aug 18, 2021 Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years
India’s vaccine endeavour truly a ‘Vaccineyaan’: Renu Swarup Press Trust of India Apr 4, 2021 She said the endeavour is not just limited to vaccines but it shows overall science and technology strength
A large basket of COVID-19 vaccine candidates is important: Renu Swarup Press Trust of India Dec 5, 2020 She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and…
Bill & Melinda Gates Foundation and Grand Challenges Partners announce new initiatives to… EP News Bureau Oct 20, 2020 Three new Grand Challenges are being launched this week to harness innovation around emerging technologies.
Government-funded Centre for Biopharma Analysis set up in Pune EP News Bureau Aug 15, 2020 It has numerous high-end instrumentation facilities worth Rs 10 crore and is expected to fast track research under biopharma in…
Five sites in India ready for Oxford-AstraZeneca COVID-19 vaccine trial: DBT EP News Bureau Jul 28, 2020 The vaccine is in its third phase of human trials, Serum Institute of India is partnering Oxford and AstraZeneca to manufacture…
Female workforce in pharma: Knocking on the glass ceiling? Tarannum Rana Mar 2, 2020 With roughly only one women out of ten professionals constituting the workforce of the Indian pharma industry, it seems that it…